Praxa Sense received ZonMW subsidy
Praxa Sense received €15.000 from ZonMW to transform Afi into a home monitoring device for COVID-19 patients. With this subsidy, Praxa Sense can add oxygen saturation (SpO2) sensors to Afi. Oxygen saturation is a vital parameter that indicates the blood’s oxygen level.
Praxa Sense develops Afi, a medical multi-sensor system that can detect heart rhythm disorders early by continuous monitoring.
Afi monitors heart rate, respiratory rate, ECG and patient activity with an ECG, PPG- and IMU sensor. The PPG-sensor will be adjusted to enable monitoring oxygen saturation as well. Praxa Sense received ZonMW subsidy to complete this project. Within the ZonMW project, the oxygen saturation sensor be developed, validated and manufactured.
Leonard Moonen (CEO) and Muriël van Oers (Clinical Research Coordinator), were invited to join a video production of ZonMW. Click here to watch the video.
Read more about Afi on our Product page or Contact Us.